Anthony Fauci Receives Lienhard Award From National Academy of Medicine for Decades of Work Improving Public Health and Leadership in Shaping COVID-19 Pandemic Response
For his role as a leader of federal research and policy on infectious diseases and, in particular, for his deft, scientifically grounded leadership in shaping an effective response to the COVID-19 pandemic, the National Academy of Medicine today announced Anthony S. Fauci is the recipient of the 2020 Gustav O. Lienhard Award for Advancement of Health Care. The award will be presented at the National Academy of Medicine’s virtual annual meeting on Oct. 19. Fauci is the director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and has served in that position since 1984.
At NIAID, Fauci oversees an extensive portfolio of basic and applied research to prevent, diagnose, and treat infectious diseases such as HIV/AIDS, tuberculosis, and malaria, as well as emerging and re-emerging diseases such as Ebola and Zika. During his career at NIAID, he has advised six U.S. presidents on many domestic and global health issues. Fauci has made many contributions to basic and clinical research on the pathogenesis and treatment of immune-mediated and infectious diseases. He made important scientific observations that underpin the current understanding of the regulation of the human immune response, which helped pioneer the field of human immunoregulation.